amway: Amway puts India in top three priority markets globally – Times of India

CHENNAI: Direct-selling company Amway has put India in one of its top three priority markets globally, along with the United States and China.
“In terms of sales, India is in top 10, and in terms of long-term investments and growth, it is among the top three, along with the US and China,” said Milind Pant, global CEO, Amway.
The company has plants in these three markets and a significant part of its $300-million global investment will come to India. “We are investing in manufacturing, in product development, organic farming, social media and marketing,” he added.
Amway had announced an investment of over $20 million (Rs 170 crore) to boost research and development, manufacturing automation, innovation & science and strengthen digital capabilities in India.
Critical to the India story is Amway’s foray into the ayurveda segment with its Nutrilite brand. Amway, which frayed into ayurveda with a Nutrilite chawanprash earlier this year, will add more products to make its ayurveda range a key component of its wellness range. “Our plan is to provide holistic wellness solutions and we want to use ayurveda and Charak Samhita’s knowledge and combine it with the efficacy of science and botanicals, so there will be many more products that will come.”
For Amway, Ayurveda is a “long-term journey” and the company will “invest in organic farming partnerships, botanicals and alliances” with top universities (it has recently tied up with IIT Mumbai).
The reason for the ayurveda aggression is clear — from “very low percentile, ayurveda products are now 8-10% of our sales turnover,” said Pant. The company is focussing on “preventive wellness” where “the wisdom of ayurveda is very critical”.
The company, which has just started exports with Indonesia, is also planning to get aggressive on that front. “Even during the pandemic with all the disruptions we have initiated exports to Indonesia and we will continue to grow especially to South East Asia,” said Pant.

Source link